TransMed7

A World Of Challenges. One Solution.

Precision, control, effortless penetration — the hummingbird is nature’s most skillful surgeon. Zero5 technology leverages these principles to unlock the power of repeatable access to every area of the body to remove, reveal, deliver or replace. Enter the new frontier.  

Zero5

SpeedBird

Concorde

Cardinal

ABOUT

Who We Are
And What We Do

TransMed7 is a privately-held medical technology company founded in 2010 to generate transformational technologies for diverse fields of healthcare around the world.

Our products are designed to address critical healthcare needs in medical fields such as: breast health; soft tissue surgery, including small or fragile tissues and challenging surgical spaces, with endoscopy, laparoscopy, and robotics applications; bone marrow biopsy and harvest; interventional cardiology; and minimally invasive peripheral vascular procedures.

Each product that we develop is designed to be highly cost-effective, because to truly serve a world population means ensuring that emerging countries can afford the healthcare products that they need.

News & Announcements

Concorde Is Now Available

Concorde Is Now Available

TransMed7, LLC announced today the availability of Concorde, the stereotactic table variant of its SpeedBird Biopsy Device Platform…
Appointment of Carin Fradin

Appointment of Carin Fradin

TransMed7, LLC is delighted to announce the appointment of Carin Fradin as a member of its Business Advisory…
Appointment of Michael J. Cyrus

Appointment of Michael J. Cyrus

TransMed7, LLC is delighted to announce the appointment of Michael J. Cyrus as a member of its Business…
Appointment of John B. Simpson, Ph.D

Appointment of John B. Simpson, Ph.D

TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to…
FDA Clearance for SpeedBird

FDA Clearance for SpeedBird

TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform  …
Strategic Engagement with Wilson Sonsini Goodrich and Rosati

Strategic Engagement with Wilson Sonsini Goodrich and Rosati

TransMed7, LLC Announces Strategic Engagement with Wilson Sonsini Goodrich and Rosati   TransMed7, LLC, announced a Strategic Engagement…

Want to Know More?

For further information on TransMed7 and its platform technologies,
please reach out to us using the form below.